In support, findings suggested that Telmisartan inhibited human esophageal adenocarcinoma (EAC) cell proliferation and tumor growth by inducing cell-cycle arrest via the AMPKα/mTOR pathway in EAC cells [332]. This evidence concerns the gene MTOR and neoplasm.